Bharat Immunologicals & Biologicals Corporation Limited (BIBCL.BO)
INR 24.03
(-1.15%)
INR 24.03
(-1.15%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2022 | 446.09 Million INR | -43.09% |
| 2021 | 783.88 Million INR | -8.14% |
| 2020 | 853.33 Million INR | 27.68% |
| 2019 | 668.36 Million INR | -20.1% |
| 2018 | 836.45 Million INR | 140.37% |
| 2017 | 347.98 Million INR | -71.98% |
| 2016 | 1.24 Billion INR | -3.01% |
| 2015 | 1.28 Billion INR | -12.44% |
| 2014 | 1.46 Billion INR | -27.88% |
| 2013 | 2.02 Billion INR | 17.34% |
| 2012 | 1.72 Billion INR | 272.88% |
| 2011 | 463.41 Million INR | 1716.12% |
| 2010 | 25.51 Million INR | -10.06% |
| 2009 | 28.37 Million INR | -60.09% |
| 2008 | 71.08 Million INR | -47.29% |
| 2007 | 134.85 Million INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 Q2 | - INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2022 Q2 | 264.79 Million INR | 152.69% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q1 | 104.79 Million INR | -52.45% |
| 2022 FY | 446.09 Million INR | -43.09% |
| 2022 Q4 | 76.5 Million INR | 0.0% |
| 2021 Q1 | 142.15 Million INR | -9.01% |
| 2021 Q2 | 247.01 Million INR | 73.77% |
| 2021 FY | 783.88 Million INR | -8.14% |
| 2021 Q3 | 174.3 Million INR | -29.44% |
| 2021 Q4 | 220.4 Million INR | 26.45% |
| 2020 Q2 | 253.58 Million INR | 32.4% |
| 2020 Q1 | 191.52 Million INR | -17.63% |
| 2020 Q4 | 156.23 Million INR | -38.0% |
| 2020 Q3 | 251.98 Million INR | -0.63% |
| 2020 FY | 853.33 Million INR | 27.68% |
| 2019 Q2 | 81.01 Million INR | 15.74% |
| 2019 Q4 | 232.51 Million INR | -18.37% |
| 2019 Q3 | 284.84 Million INR | 251.6% |
| 2019 FY | 668.36 Million INR | -20.1% |
| 2019 Q1 | 69.99 Million INR | -90.09% |
| 2018 Q1 | 867 Thousand INR | -99.6% |
| 2018 Q3 | 82.8 Million INR | 77.24% |
| 2018 FY | 836.45 Million INR | 140.37% |
| 2018 Q4 | 706.05 Million INR | 752.63% |
| 2018 Q2 | 46.72 Million INR | 5288.93% |
| 2017 Q2 | 53.05 Million INR | 58.51% |
| 2017 Q4 | 216.8 Million INR | 385.52% |
| 2017 Q3 | 44.65 Million INR | -15.83% |
| 2017 Q1 | 33.46 Million INR | -94.54% |
| 2017 FY | 347.98 Million INR | -71.98% |
| 2016 FY | 1.24 Billion INR | -3.01% |
| 2016 Q2 | 110.08 Million INR | -60.39% |
| 2016 Q3 | 240.42 Million INR | 118.41% |
| 2016 Q4 | 613.41 Million INR | 155.14% |
| 2016 Q1 | 277.92 Million INR | -52.89% |
| 2015 Q4 | 589.9 Million INR | 51.06% |
| 2015 Q2 | 134.12 Million INR | -19.1% |
| 2015 Q1 | 165.78 Million INR | -29.57% |
| 2015 FY | 1.28 Billion INR | -12.44% |
| 2015 Q3 | 390.51 Million INR | 191.17% |
| 2014 Q4 | 235.41 Million INR | -63.15% |
| 2014 Q3 | 638.78 Million INR | 157.26% |
| 2014 Q2 | 248.3 Million INR | -26.91% |
| 2014 FY | 1.46 Billion INR | -27.88% |
| 2014 Q1 | 339.71 Million INR | -67.26% |
| 2013 Q1 | 154.42 Million INR | -78.02% |
| 2013 Q2 | 250.4 Million INR | 62.16% |
| 2013 Q3 | 585.18 Million INR | 133.69% |
| 2013 Q4 | 1.03 Billion INR | 77.3% |
| 2013 FY | 2.02 Billion INR | 17.34% |
| 2012 Q2 | 203.89 Million INR | 51.81% |
| 2012 FY | 1.72 Billion INR | 272.88% |
| 2012 Q1 | 134.31 Million INR | -69.41% |
| 2012 Q3 | 687.32 Million INR | 237.1% |
| 2012 Q4 | 702.45 Million INR | 2.2% |
| 2011 FY | 463.41 Million INR | 1716.12% |
| 2011 Q3 | 20.4 Million INR | 0.0% |
| 2011 Q4 | 439.01 Million INR | 2051.5% |
| 2010 FY | 25.51 Million INR | -10.06% |
| 2009 FY | 28.37 Million INR | -60.09% |
| 2009 Q4 | 17.21 Million INR | 0.0% |
| 2008 FY | 71.08 Million INR | -47.29% |
| 2008 Q4 | 68.06 Million INR | 0.0% |
| 2007 Q4 | 76.57 Million INR | 0.0% |
| 2007 FY | 134.85 Million INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| ANG Lifesciences India Limited | 1.46 Billion INR | 69.469% |
| DECIPHER LABS LIMITED | 362.75 Million INR | -22.974% |
| Ishita Drugs and Industries Limited | 151.87 Million INR | -193.721% |
| Jenburkt Pharmaceuticals Limited | 1.41 Billion INR | 68.578% |
| Patidar Buildcon Limited | 2.3 Million INR | -19228.033% |
| Sanjivani Paranteral Limited. | 536.87 Million INR | 16.909% |
| SHAMROCK INDUSTRIAL CO.LTD. | 1.11 Million INR | -39800.805% |
| Source Natural Foods and Herbal Supplements Limited | 272.96 Million INR | -63.422% |
| Sunil Healthcare Limited | 901.91 Million INR | 50.54% |
| MedPlus Health Services Limited | 56.24 Billion INR | 99.207% |
| KIMIA BIOSCIENCES LIMITED | 1.04 Billion INR | 57.465% |
| Add-Shop E-Retail Limited | 2.02 Billion INR | 77.926% |
| Bacil Pharma Limited | - INR | -Infinity% |
| BDH Industries Limited | 858.31 Million INR | 48.027% |
| Beryl Drugs Limited | 271.24 Million INR | -64.459% |
| Cian Healthcare Limited | 616.95 Million INR | 27.695% |
| Concord Drugs Limited | 449.24 Million INR | 0.702% |
| Deccan Health Care Limited | 597.28 Million INR | 25.314% |
| Gujarat Terce Laboratories Limited | 479.74 Million INR | 7.015% |
| Gujarat Themis Biosyn Limited | 1.69 Billion INR | 73.732% |
| Medi-Caps Limited | 265.63 Million INR | -67.934% |
| Parmax Pharma Limited | 154.24 Million INR | -189.212% |
| Sastasundar Ventures Limited | 13.56 Billion INR | 96.71% |
| Smruthi Organics Limited | 1.27 Billion INR | 65.052% |
| SUDARSHAN PHARMA INDUSTRIES LI | 4.63 Billion INR | 90.376% |
| Phaarmasia Limited | 305.93 Million INR | -45.813% |
| Syschem (India) Limited | 2.33 Billion INR | 80.898% |
| Transchem Limited | 4.09 Million INR | -10780.271% |
| Trinity League India Limited | 2.95 Million INR | -15021.729% |
| Tyche Industries Limited | 696.83 Million INR | 35.983% |
| Vista Pharmaceuticals Limited | 102.87 Million INR | -333.612% |
| Zenith Healthcare Limited | 144.71 Million INR | -208.251% |
| Chemo Pharma Laboratories Limited | 18.38 Million INR | -2326.782% |
| Colinz Laboratories Limited | 70.29 Million INR | -534.589% |
| Denis Chem Lab Limited | 1.67 Billion INR | 73.419% |
| Hindustan Bio Sciences Limited | 10.48 Million INR | -4152.724% |
| Kwality Pharmaceuticals Limited | 3.07 Billion INR | 85.477% |
| Makers Laboratories Limited | 1.03 Billion INR | 57.009% |
| Panchsheel Organics Limited | 1.05 Billion INR | 57.603% |
| Parnax Lab Limited | 1.88 Billion INR | 76.361% |
| PRAVEG LIMITED | 915.96 Million INR | 51.298% |
| Mercury Laboratories Limited | 755.59 Million INR | 40.961% |
| Trident Lifeline Limited | 446.28 Million INR | 0.044% |
| Vikram Thermo (India) Limited | 1.25 Billion INR | 64.43% |
| Vivanza Biosciences Limited | 278.89 Million INR | -59.951% |
| Zenlabs Ethica Limited | 585.63 Million INR | 23.827% |
| SHELTER PHARMA LIMITED | 400.22 Million INR | -11.459% |
| Vasundhara Rasayans Limited | 370.18 Million INR | -20.505% |
| Roopa Industries Limited | 715.53 Million INR | 37.656% |
| PANJON LTD. | 125.52 Million INR | -255.392% |
| Pharmaids Pharmaceuticals Limited | 151.12 Million INR | -195.188% |
| TIAAN CONSUMER LIMITED | - INR | -Infinity% |
| Anuh Pharma Limited | 6.47 Billion INR | 93.105% |
| Crestchem Limited | 212.56 Million INR | -109.864% |
| Emmessar Biotech & Nutrition Limited | 5.55 Million INR | -7934.78% |
| Sandu Pharmaceuticals Limited | 672.8 Million INR | 33.697% |
| Fredun Pharmaceuticals Limited | 3.48 Billion INR | 87.187% |
| Trimurthi Limited | 42.23 Million INR | -956.137% |
| Shukra Pharmaceuticals Limited | 745.72 Million INR | 40.181% |
| Norris Medicines Limited | 56.35 Million INR | -691.557% |
| Veerhealth Care Limited | 142.13 Million INR | -213.852% |
| Lactose (India) Limited | 1.13 Billion INR | 60.831% |
| OXYGENTA PHARMACEUTICAL LIMITE | 396.42 Million INR | -12.53% |
| Ambalal Sarabhai Enterprises Limited | 1.74 Billion INR | 74.411% |
| Gennex Laboratories Limited | 867.14 Million INR | 48.556% |
| Godavari Drugs Limited | 1.56 Billion INR | 71.534% |
| Zenotech Laboratories Limited | 368.08 Million INR | -21.191% |
| Shree Ganesh Remedies Limited | 1.25 Billion INR | 64.567% |
| Bharat Parenterals Limited | 2.59 Billion INR | 82.804% |
| Coral Laboratories Limited | 836.6 Million INR | 46.678% |
| Evoq Remedies Limited | 63.09 Million INR | -607.071% |
| Kerala Ayurveda Limited | 1.02 Billion INR | 56.409% |
| KOBO BIOTECH LIMITED | - INR | -Infinity% |
| Natural Capsules Limited | 1.55 Billion INR | 71.298% |
| Auro Laboratories Limited | 526.99 Million INR | 15.352% |